Ohio Innovation Fund

Ohio Innovation Fund, founded in 1997 and based in Cleveland, Ohio, is a venture capital firm that specializes in early stage and startup investments in the technology sector. With a focus on providing capital and expertise to companies based in or connected to Ohio, the firm typically invests between $250,000 and $500,000, with the possibility of up to $1.25 million based on milestones. Their investment strategy targets technology and life sciences companies, aiming to support and drive innovation in the region.

Faith Voinovich

Principal

52 past transactions

Alviere

Series A in 2018
Developer of an embedded finance platform designed to empower brands to offer financial services to their customers. The company's software and services give businesses a flexible framework to launch new financial service lines of business aimed at increasing profits, enabling customer relationships and insights, and increasing customer satisfaction and retention.

Aware

Series B in 2020
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise. They have only built a fraction of what they imagined and now they are looking for incredibly talented people to help us achieve their aspirational vision.

ConnXus

Private Placement in 2018
ConnXus supplier management solutions simplify the complexities of global supply chains and allow buyers to achieve their goals of responsible and sustainable sourcing. ConnXus is a NMSDC, CPUC, CAMSC and State of Ohio-certified minority-owned business enterprise based in Mason, Ohio with local, regional and international capabilities.

Eccrine Systems

Series B in 2018
Eccrine Systems, Inc. develops and commercializes non-invasive, electronic wearable systems that measure and transmit real-time data about human sweat. It offers Sweatronics platform, a modular, wearables system that is used to measure multiple different analytes in sweat, as well as wirelessly transmits data via a transceiver to remote applications. The company's advanced sweat sensor technologies are used in medicine, industry, and sports applications. The company was founded in 2013 and is based in Cincinnati, Ohio.

Aware

Series A in 2017
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise. They have only built a fraction of what they imagined and now they are looking for incredibly talented people to help us achieve their aspirational vision.

eFuse

Venture Round in 2021
eFuse is a web & mobile application for the Esports & Video Game industry. eFuse allows individuals to establish their gaming identity and participate in the industry at all levels. Whether it be learning about the industry, networking with other like-minded individuals, or accessing opportunities like jobs & scholarships, eFuse has something for everyone.

Enable Injections

Series C in 2022
Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

Aware

Series A in 2017
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise. They have only built a fraction of what they imagined and now they are looking for incredibly talented people to help us achieve their aspirational vision.

Immuta

Series C in 2020
Immuta provides a cloud-native data governance platform for organizations to automate data access control, security and privacy compliance, ensuring each user who queries data sees only the data they’re supposed to see, for their approved purpose or role. The platform aims to create trust across data engineering, security, legal, compliance, and business teams so they can work together to ensure timely access to critical data with minimal risk, while adhering to global data privacy regulations including the GDPR, CCPA and HIPAA.

Genetesis

Series A in 2018
Genetesis LLC designs, develops, and provides biomagnetic imaging solutions. The company offers Genetesis CardioFlux, a mapping system that optimizes the detection, characterization, and treatment of cardiac rhythm disorders; and Faraday Analytical Cloud, a HIPAA-Compliant technology platform that manages the end to end data workflow for the CardioFlux Magnetocardiograph (MCG). Its systems also visualize electrical currents of heart in 3D. Genetesis LLC was founded in 2013 and is headquartered in Mason, Ohio.

Complion

Private Placement in 2019
Complion platform offers tremendous benefits to every role in the clinical trial ecosystem. It allows administrators and research coordinators to more efficiently maintain compliance protocols. It unleashes investigators to explore potential innovation with fewer hassles. It streamlines crucial information that auditors and quality assurance personnel need and it permits collaborators and reviewers to more easily participate in clinical research.

ScriptDrop

Private Placement in 2020
ScriptDrop’s technology platform enables connectivity across the healthcare ecosystem connecting patients, pharmacists, providers, and pharmaceutical manufacturers. The platform provides a seamless experience for patients, offering them prescription delivery in all 50 states and allowing for important additional services to be provided for better adherence. The company was founded in 2016 and is headquartered in Columbus, Ohio.

ScriptDrop

Series A in 2020
ScriptDrop’s technology platform enables connectivity across the healthcare ecosystem connecting patients, pharmacists, providers, and pharmaceutical manufacturers. The platform provides a seamless experience for patients, offering them prescription delivery in all 50 states and allowing for important additional services to be provided for better adherence. The company was founded in 2016 and is headquartered in Columbus, Ohio.

Able

Private Placement in 2019
Able Software Inc. develops and operates a Software-as-a-Service platform that automates the hiring and onboarding process for employers. Its platform provides careers portal/job board, Form I-9 and e-verify, online application, background checks, paperless onboarding, drug screening, employee portal, verification services, employee self-service, applicant pre-screening, real-time alerting, and interview screening services. The company was formerly known as EmployStream, Inc. and changed its name to Able Software Inc. in August 2020. Able Software Inc. was founded in 2014 and is based in Cleveland, Ohio.

RXQ Compounding

Series A in 2018
RXQ Compounding, LLC manufactures and distributes sterile and non-sterile medications in the United States. The company offers sterile and non-sterile injectable products, veterinary medications, dermatologic creams and ointments, ophthalmic solutions, orthopedic steroids, and custom production products for hospitals. It sells its products online. The company was founded in 2014 and is based in Athens, Ohio.

Genetesis

Private Placement in 2020
Genetesis LLC designs, develops, and provides biomagnetic imaging solutions. The company offers Genetesis CardioFlux, a mapping system that optimizes the detection, characterization, and treatment of cardiac rhythm disorders; and Faraday Analytical Cloud, a HIPAA-Compliant technology platform that manages the end to end data workflow for the CardioFlux Magnetocardiograph (MCG). Its systems also visualize electrical currents of heart in 3D. Genetesis LLC was founded in 2013 and is headquartered in Mason, Ohio.

eFuse, Inc.

Private Placement in 2019
eFuse, Inc. operates in the technology industry. The company was incorporated in 2018 and is based in Columbus, Ohio.

RXQ Compounding

Private Placement in 2018
RXQ Compounding, LLC manufactures and distributes sterile and non-sterile medications in the United States. The company offers sterile and non-sterile injectable products, veterinary medications, dermatologic creams and ointments, ophthalmic solutions, orthopedic steroids, and custom production products for hospitals. It sells its products online. The company was founded in 2014 and is based in Athens, Ohio.

Clarametyx Biosciences

Private Placement in 2020
Clarametyx Biosciences, Inc., a biotechnology company, develops targeted and immune-enabling biologic therapies to counter persistent infections associated with biofilms. It offers a technology platform that targets the biofilm, a protective layer around bacteria to enable immune response and antibiotic intervention; and CMTX-001, is a humanized monoclonal antibody in preclinical development for hospital-acquired pneumonia. Clarametyx Biosciences, Inc. was founded in 2020 and is based in Columbus, Ohio.

ConnXus

Series A in 2018
ConnXus supplier management solutions simplify the complexities of global supply chains and allow buyers to achieve their goals of responsible and sustainable sourcing. ConnXus is a NMSDC, CPUC, CAMSC and State of Ohio-certified minority-owned business enterprise based in Mason, Ohio with local, regional and international capabilities.

Mezu

Venture Round in 2018
Mezu is a mobile payment app that gives you a private and secure way to give and get money without sharing your personal information. Just like cash, with Mezu, you can conveniently pay, tip, earn and donate safely and for free. Because Mezu believes that what you do with your money is your business. Mezu is now available on iOS and Android in the United States. Sign up and learn more: https://www.mezu.com.

Immuta

Series B in 2018
Immuta provides a cloud-native data governance platform for organizations to automate data access control, security and privacy compliance, ensuring each user who queries data sees only the data they’re supposed to see, for their approved purpose or role. The platform aims to create trust across data engineering, security, legal, compliance, and business teams so they can work together to ensure timely access to critical data with minimal risk, while adhering to global data privacy regulations including the GDPR, CCPA and HIPAA.

Able

Private Placement in 2018
Able Software Inc. develops and operates a Software-as-a-Service platform that automates the hiring and onboarding process for employers. Its platform provides careers portal/job board, Form I-9 and e-verify, online application, background checks, paperless onboarding, drug screening, employee portal, verification services, employee self-service, applicant pre-screening, real-time alerting, and interview screening services. The company was formerly known as EmployStream, Inc. and changed its name to Able Software Inc. in August 2020. Able Software Inc. was founded in 2014 and is based in Cleveland, Ohio.
EmployStream is a hiring workflow automation software platform for staffing companies and other high-volume employers. It also creates high-quality, user-friendly for high-volume employers that automates the hiring and onboarding process for employers. The platform eliminates costly mistakes and delays allowing companies to hire up to 90% faster and at half the cost. The company provides an online hiring platform which offers different features such as paper onboarding, real-time alerting, online application, background checks, applicant pre & interview screening, and verification. EmployStream was founded in 2014 and is headquartered in Cleveland Ohio, USA.

Clarametyx Biosciences

Series A in 2024
Clarametyx Biosciences, Inc., a biotechnology company, develops targeted and immune-enabling biologic therapies to counter persistent infections associated with biofilms. It offers a technology platform that targets the biofilm, a protective layer around bacteria to enable immune response and antibiotic intervention; and CMTX-001, is a humanized monoclonal antibody in preclinical development for hospital-acquired pneumonia. Clarametyx Biosciences, Inc. was founded in 2020 and is based in Columbus, Ohio.

AKRU

Seed Round in 2022
Tokenism is a marketplace (platform for creating and trading Fractionalized real estate) for Real Estate backed security tokens. The first of its kind platform is set to have all appropriate regulatory approvals and launch the beta version in Q2 of 2020. The company is utilizing Blockchain & AI to back its platform. Tokenism provides its clients with a complete set of diligence documents & a summary of the properties historic performance. It enables its investors to gain liquidity in an extremely ill liquid market & treat their real estate investments more like stock portfolios, focusing on asset allocation, rather than independently researching & evaluating various commercial real estate opportunities and investing portion of wealth in a single asset while reaping the benefits of direct investment and liquidity through a marketplace for initial offerings & secondary trades of all tokens created on the platform

Stirling Ultracold

Series B in 2018
Stirling Ultracold, a division of Global Cooling, Inc., is a developer and manufacturer of a new generation of environmentally friendly ultra-low temperature freezers which operate below -86°C. These freezers do not use dry ice, Peltier or conventional cascade refrigeration systems. Instead, the Stirling Ultracold product line operates on free-piston Stirling engine technology.

Genetesis

Series B in 2020
Genetesis LLC designs, develops, and provides biomagnetic imaging solutions. The company offers Genetesis CardioFlux, a mapping system that optimizes the detection, characterization, and treatment of cardiac rhythm disorders; and Faraday Analytical Cloud, a HIPAA-Compliant technology platform that manages the end to end data workflow for the CardioFlux Magnetocardiograph (MCG). Its systems also visualize electrical currents of heart in 3D. Genetesis LLC was founded in 2013 and is headquartered in Mason, Ohio.

S4 Medical

Series A in 2021
Sotera is a medical device company focused on innovative solutions for cardiac procedures. The company’s initial product is a solution for reducing complications to the esophagus during catheter ablation treatment for atrial fibrillation.It is commercializing a novel medical device designed to protect the esophagus during catheter ablation procedures.

Windpact

Venture Round in 2019
Windpact is a provider of impact protection solutions designed for sports, military, and automotive applications. The company's protection solutions are empowered with refined machine learning principles, FEA modeling, and a Crash Cloud system that automatically adjusts to manage a wide range of impact rates, protecting people anywhere exposed to the risk of impact. Windpact was founded in 2011 and is headquartered in Leesburg, Virginia.

DAtAnchor

Convertible Note in 2021
DAtAnchor develops a novel crypto-technology that anchors the data consumption within the network boundaries, serving as a backstop against inevitable breaches. It provides a secure gateway to access the files in the cloud and the database, with the added features of revocability and physical access control, enabling efficient and automated data governance. DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies.

Enable Injections

Series A in 2016
Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

DOmedia

Series A in 2016
DOmedia, LLC operates a media buying and selling platform for agencies and their brands globally. It offers RFP/Proposal Management and Vendor Management cloud-based application to manage media information and create client analytics; seller applications; and local advertiser applications. The company’s online marketplace allows media providers to create media profiles for their properties; and advertisers and agencies to use the database of media properties to find new ideas, plan, and build out-of-home campaigns. DOmedia, LLC was founded in 2007 and is based in Columbus, Ohio.

DAtAnchor

Seed Round in 2018
DAtAnchor develops a novel crypto-technology that anchors the data consumption within the network boundaries, serving as a backstop against inevitable breaches. It provides a secure gateway to access the files in the cloud and the database, with the added features of revocability and physical access control, enabling efficient and automated data governance. DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies.

Aware

Series C in 2021
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise. They have only built a fraction of what they imagined and now they are looking for incredibly talented people to help us achieve their aspirational vision.

S4 Medical

Venture Round in 2020
Sotera is a medical device company focused on innovative solutions for cardiac procedures. The company’s initial product is a solution for reducing complications to the esophagus during catheter ablation treatment for atrial fibrillation.It is commercializing a novel medical device designed to protect the esophagus during catheter ablation procedures.

S4 Medical

Private Placement in 2019
Sotera is a medical device company focused on innovative solutions for cardiac procedures. The company’s initial product is a solution for reducing complications to the esophagus during catheter ablation treatment for atrial fibrillation.It is commercializing a novel medical device designed to protect the esophagus during catheter ablation procedures.

Genetesis

Private Placement in 2018
Genetesis LLC designs, develops, and provides biomagnetic imaging solutions. The company offers Genetesis CardioFlux, a mapping system that optimizes the detection, characterization, and treatment of cardiac rhythm disorders; and Faraday Analytical Cloud, a HIPAA-Compliant technology platform that manages the end to end data workflow for the CardioFlux Magnetocardiograph (MCG). Its systems also visualize electrical currents of heart in 3D. Genetesis LLC was founded in 2013 and is headquartered in Mason, Ohio.

eFuse

Seed Round in 2019
eFuse is a web & mobile application for the Esports & Video Game industry. eFuse allows individuals to establish their gaming identity and participate in the industry at all levels. Whether it be learning about the industry, networking with other like-minded individuals, or accessing opportunities like jobs & scholarships, eFuse has something for everyone.

Aware

Series A in 2018
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise. They have only built a fraction of what they imagined and now they are looking for incredibly talented people to help us achieve their aspirational vision.

Global Cooling, Inc.

Private Placement in 2018
Global Cooling, Inc. manufactures and sells ultra-low temperature freezers for energy, aerospace, life science, pharmaceutical, bioresearch/clinical, biotechnology, and industrial applications, as well as scientific corporations and organizations worldwide. It also provides direct training of authorized service personnel. The company sells its products directly and through laboratory supply dealers. Global Cooling, Inc. was founded in 1995 and is headquartered in Athens, Ohio.

Immuta

Series A in 2017
Immuta provides a cloud-native data governance platform for organizations to automate data access control, security and privacy compliance, ensuring each user who queries data sees only the data they’re supposed to see, for their approved purpose or role. The platform aims to create trust across data engineering, security, legal, compliance, and business teams so they can work together to ensure timely access to critical data with minimal risk, while adhering to global data privacy regulations including the GDPR, CCPA and HIPAA.

Mezu

Private Placement in 2017
Mezu is a mobile payment app that gives you a private and secure way to give and get money without sharing your personal information. Just like cash, with Mezu, you can conveniently pay, tip, earn and donate safely and for free. Because Mezu believes that what you do with your money is your business. Mezu is now available on iOS and Android in the United States. Sign up and learn more: https://www.mezu.com.

Enable Injections

Series B in 2018
Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.
EmployStream is a hiring workflow automation software platform for staffing companies and other high-volume employers. It also creates high-quality, user-friendly for high-volume employers that automates the hiring and onboarding process for employers. The platform eliminates costly mistakes and delays allowing companies to hire up to 90% faster and at half the cost. The company provides an online hiring platform which offers different features such as paper onboarding, real-time alerting, online application, background checks, applicant pre & interview screening, and verification. EmployStream was founded in 2014 and is headquartered in Cleveland Ohio, USA.

Spirosure

Series C in 2016
Spirometrix is a California-based company, focusing on research, development, and commercialization of novel breath analysis devices for application in disease diagnosis and management. Founded in 2012, the company's mission is to provide cost-effective, non-invasive products for the management of chronic diseases such as asthma, COPD, and chronic pulmonary hypertension using a nexus of consumer technologies for preventative healthcare through our proprietary set of sensors and algorithms. The target of their first commercial product is a device that facilitates the diagnosis and management of airway inflammation (asthma) in the physician's office. The product under development is a novel diagnostic medical device to detect exhaled nitric oxide in the breath of a patient.

Nullable, Inc.

Private Placement in 2020
Nullable, Inc. develops and provides a platform for enterprise social networks. It offers Aware, a security platform that monitors and secures enterprise social networks, including public and private conversations, files, and feeds. The company’s products include Aware risk management, Aware spotlight, and Aware digital signage. Nullable, Inc. was formerly known as Null, Ltd. The company was incorporated in 2017 and is based in Columbus, Ohio.

Complion

Series B in 2019
Complion platform offers tremendous benefits to every role in the clinical trial ecosystem. It allows administrators and research coordinators to more efficiently maintain compliance protocols. It unleashes investigators to explore potential innovation with fewer hassles. It streamlines crucial information that auditors and quality assurance personnel need and it permits collaborators and reviewers to more easily participate in clinical research.

Niobium Microsystems

Seed Round in 2024
Niobium Microsystems creates custom integrated circuit and microelectronic system solutions for clients with complex power, performance, and security constraints.

Lentechs

Venture Round in 2023
Lentechs is a medical device company that develops a novel soft bifocal contact lens. The company is headquartered in Columbus, Ohio.

Genetesis

Series C in 2022
Genetesis LLC designs, develops, and provides biomagnetic imaging solutions. The company offers Genetesis CardioFlux, a mapping system that optimizes the detection, characterization, and treatment of cardiac rhythm disorders; and Faraday Analytical Cloud, a HIPAA-Compliant technology platform that manages the end to end data workflow for the CardioFlux Magnetocardiograph (MCG). Its systems also visualize electrical currents of heart in 3D. Genetesis LLC was founded in 2013 and is headquartered in Mason, Ohio.